Literature DB >> 28941454

Components of the Hepatocellular Carcinoma Microenvironment and Their Role in Tumor Progression.

M V Novikova1, N V Khromova, P B Kopnin.   

Abstract

This review summarizes recently published data on the mechanisms of tumor cell interaction with the tumor microenvironment. Tumor stroma influences the processes of hepatocarcinogenesis, epithelial-to-mesenchymal transition, invasion, and metastasis. The tumor microenvironment includes both cellular and noncellular components. Main cellular components of hepatocellular carcinoma (HCC) stroma are tumor-associated fibroblasts, hepatic stellate cells, immune cells, and endothelial cells that produce extracellular components of tumor microenvironment such as extracellular matrix, various proteins, proteolytic enzymes, growth factors, and cytokines. The noncellular components of the stroma modulate signaling pathways in tumor cells and stimulate invasion and metastasis. The tumor microenvironment composition and organization can serve as prognostic factors in HCC pathogenesis. Current approaches in HCC targeted therapy are aimed at creating efficient strategies for interrupting tumor interactions with the stroma. Recent data on the composition and role of the microenvironment in HCC pathogenesis, as well as new developments in antitumor drug design are discussed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28941454     DOI: 10.1134/S0006297917080016

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  27 in total

1.  C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.

Authors:  Brian I Carr; Hikmet Akkiz; Vito Guerra; Oguz Üsküdar; Sedef Kuran; Ümit Karaoğullarından; Salih Tokmak; Tuğsan Ballı; Abdulalh Ülkü; Tolga Akçam; Anıl Delik; Burcu Arslan; Figen Doran; Kendal Yalçın; Engin Altntaş; Ayşegül Özakyol; Mehmet Yücesoy; Halil İbrahim Bahçeci; Kamil Yalçın Polat; Nazım Ekinci; Halis Şimşek; Necat Örmeci; Abdulalh Sonsuz; Mehmet Demir; Murat Kılıç; Ahmet Uygun; Ali Demir; Sezai Yilmaz; Yaman Tokat
Journal:  Clin Pract (Lond)       Date:  2018

2.  An M0 macrophage-related prognostic model for hepatocellular carcinoma.

Authors:  Yiya Zhang; Ju Zou; Ruochan Chen
Journal:  BMC Cancer       Date:  2022-07-19       Impact factor: 4.638

3.  M2 macrophage-derived extracellular vesicles facilitate CD8+T cell exhaustion in hepatocellular carcinoma via the miR-21-5p/YOD1/YAP/β-catenin pathway.

Authors:  Jian Pu; Zuoming Xu; Jiahui Nian; Quan Fang; Meng Yang; Youguan Huang; Wenchuan Li; Bin Ge; Jianchu Wang; Huamei Wei
Journal:  Cell Death Discov       Date:  2021-07-16

Review 4.  Metabolic Symbiosis and Immunomodulation: How Tumor Cell-Derived Lactate May Disturb Innate and Adaptive Immune Responses.

Authors:  Alexandre Morrot; Leonardo Marques da Fonseca; Eduardo J Salustiano; Luciana Boffoni Gentile; Luciana Conde; Alessandra Almeida Filardy; Tatiany Nunes Franklim; Kelli Monteiro da Costa; Celio Geraldo Freire-de-Lima; Leonardo Freire-de-Lima
Journal:  Front Oncol       Date:  2018-03-23       Impact factor: 6.244

5.  Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma.

Authors:  Gang Ning; Yan-Lin Huang; Li-Min Zhen; Wen-Xiong Xu; Xue-Jun Li; Li-Na Wu; Ying Liu; Chan Xie; Liang Peng
Journal:  Biomed Res Int       Date:  2020-06-14       Impact factor: 3.411

6.  A new risk model comprising genes highly correlated with CD133 identifies different tumor-immune microenvironment subtypes impacting prognosis in hepatocellular carcinoma.

Authors:  Huajian Yu; Xiaoqiang Zhu; Hechun Lin; Hongyu Pan; Fangyu Zhao; Miaoxin Zhu; Lei Sun; Wenjun Chai; Ming Yao; Mingxia Yan
Journal:  Aging (Albany NY)       Date:  2020-06-20       Impact factor: 5.682

7.  Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia.

Authors:  Hui Ma; Liqi Xie; Lan Zhang; Xin Yin; Hucong Jiang; Xiaoying Xie; Rongxin Chen; Haojie Lu; Zhenggang Ren
Journal:  Commun Biol       Date:  2018-10-25

Review 8.  NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings.

Authors:  Matteo Centonze; Concetta Saponaro; Anita Mangia
Journal:  Transl Oncol       Date:  2018-02-20       Impact factor: 4.243

Review 9.  Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation.

Authors:  Matti Sällberg; Anna Pasetto
Journal:  Front Immunol       Date:  2020-03-27       Impact factor: 7.561

Review 10.  Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy.

Authors:  Zeli Yin; Keqiu Jiang; Rui Li; Chengyong Dong; Liming Wang
Journal:  Mol Cancer       Date:  2018-12-28       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.